# Trending Content OS — Daily Run
**Run date:** 2026-10-23 | **Niche:** Health & Wellness

---

## 1. Preflight Summary

| Check | Status |
|---|---|
| Config files (7/7) + CLAUDE.md skills | ✅ Present |
| `site_niche` / `target_audience` | ✅ Set |
| `site_url` | ⚠️ Not configured — self-check skipped, competitor-list fallback used |
| `minimum_trend_strength_score` / `minimum_opportunity_score` | 50 / 55 |
| Google Trends | ✅ Available via injected SerpAPI pre-fetch (`search_velocity_source: google_trends`) |
| Google News (SerpAPI) | ✅ Available (144 unique headlines, 12 queries) |
| Reddit / Exa / Social | Not confirmed this run — no material gap given strong News+Trends convergence |
| Deferred topics (`data/deferred_topics.yaml`) | None past `recheck_on` date |
| Recurring themes (run_history, 2+ consecutive runs) | None flagged as stale-recurring this run |

**next_action:** `run_signal_listener` ✅ (completed below)

---

## 2. Google News Radar Coverage Summary

Clustered 144 headlines (60 shown) into 9 main topic groups:

| Cluster | Disposition | Why |
|---|---|---|
| **FDA recalls — toothpaste (Brush Buddies EVO)** | ✅ Retained (P1) | 7+ converging outlets, consumer-safety, kids' product |
| **FDA recalls — GLP-1 (tirzepatide) sterility** | ✅ Retained (P1) | High-interest drug class, 3+ converging outlets, recall type |
| **AI-in-medicine (Microsoft diagnostic study, Stanford HAI, Nature bias review)** | ✅ Retained (P2) | Tier-1 convergence (Nature, Stanford HAI), audience-relevant angle on AI vs. doctors |
| **Pertussis Global Burden study (Nature)** | ✅ Retained (P3) | Tier-1 journal, thin competing coverage = real opportunity, but single-source confidence |
| **Marshall Faulk Parkinson's diagnosis** | ✅ Retained (P3) | Confirmed Google Trends real-time breakout + ESPN; passes borderline criteria as health-education hook |
| **Health insurance costs / employer benefits (KFF, NPR, NYT, Commonwealth Fund, Time)** | ❌ Rejected | Off-category — healthcare economics/policy, not medical/nutrition/fitness/public-health science |
| **Women's health executive order / NIH task force (HHS, PBS, ABC7)** | ❌ Rejected | Brand-safety: political framing (`allow_politics: false`); legitimate research angle could be revisited with depoliticized framing |
| **Hospital M&A (Hackensack-Hunterdon, CentraCare-Stellis)** | ❌ Rejected | Excluded category — local hospital/business news |
| **Wellness lifestyle (darties, supplement strips, local wellness fairs, Therme DC)** | ❌ Rejected | Off-category/local or borders supplement marketing exclusion |
| **Wellness misinformation (Guardian — influencer events)** | 🟡 Monitor (P5) | Passes category borderline test but trend_strength (39) falls below 50 threshold — single source, no velocity signal |
| **Clinical trial pharma business (Oracle-AstraZeneca, Syneos-Optum, rural trial access policy)** | ❌ Rejected | Excluded — pure pharma business/policy, no direct patient-facing angle |
| **PTSD "breakthrough" trial (Science Daily, 68% remission)** | ❌ Rejected at 02b | Single aggregator source, no traceable DOI/PubMed/institution — unverifiable high-risk claim |
| **Cheese recall (E. coli, Newsweek)** | ❌ Rejected at 02b | Only 1 source — breaking-recall exception requires 3+ |
| **"Tea & heart health" rising search query** | ❌ Rejected at 02b | Strong Trends signal but no corroborating primary/news source located in this run |
| **Misc (Alzheimer's Phase 2 start, genome study, CAR-T rare disease, NIH center statement, wearable trial accuracy, digital-twin preterm labor, WHO workforce gap, mental-healthcare-access study)** | ❌ Rejected/Monitor | Too early-stage, too niche, single-state scope, or low audience relevance |

---

## 3. Signal Summary

```yaml
signal_summary:
  total_signals_reviewed: 144
  total_signals_retained: 5
  total_monitor: 1
  total_rejected: 19 (clustered)
  google_trends_available: true
  search_velocity_source: google_trends
  rejection_breakdown:
    off_category: 7
    brand_safety: 1
    duplicate: 0
    weak_signal: 6
    unverified_claim: 3
    other: 2
  highest_priority_topic: "GLP-1 (tirzepatide) injection recall — sterility concerns"
  strongest_signal_source: "FDA recall news cluster (7+ independent outlets, toothpaste)"
  tools_unavailable: ["Reddit live pull", "Exa semantic search", "direct FDA.gov retrieval"]
  notes: "site_url not configured — self-check skipped; competitor coverage checked instead. Strong News+Trends convergence on food-safety/recall and GLP-1 topics this week. 'Tea & heart health' is a high rising-search term with no located primary source — recommend adding to deferred_topics.yaml for 3-day recheck."
```

---

## 4. Skill 02b Routing Summary

| Topic | Risk Type | Gate Result | Notes |
|---|---|---|---|
| Toothpaste recall | recall | **Pass** | Multi-outlet convergence names FDA; direct FDA.gov link not retrieved — verify before publish |
| GLP-1 injection recall | recall | **Pass (Medium cap)** | Breaking-recall exception used — 3 sources, none in trusted_sources.yaml tier list; verify FDA.gov notice |
| AI diagnostic accuracy study | medical_study | **Pass** | Mild overstatement flagged ("outperforms physicians") — recommend leading with narrower study language |
| Pertussis GBD study | medical_study | **Pass** | Nature journal = primary source, claim matches |
| PTSD "68% remission" trial | clinical_trial | **Reject** | Single aggregator (Science Daily), no DOI/PubMed/institution traceable |
| Cheese recall (E. coli) | recall | **Reject** | Only 1 source; breaking-recall exception requires 3+ |
| Tea & heart health study | medical_study | **Reject** | No primary source located despite strong search signal |
| Marshall Faulk / Guardian misinfo | n/a | **Not triggered** | Not high-risk claim categories |

---

## 5. Final Editorial Priority Board

| Priority | Topic | Trend | Opp. | Discover | Urgency | Confidence | Timing |
|---|---|---|---|---|---|---|---|
| **P1** | Toothpaste recall (Brush Buddies EVO) | 79 | 72 | 4 | today | medium | immediate |
| **P1** | GLP-1 (tirzepatide) injection recall | 69 | 80 | 4 | now | medium | immediate |
| **P2** | AI diagnostic accuracy vs. physicians | 63 | 67 | 3 | this_week | medium | short_term |
| **P3** | Pertussis Global Burden study | 50 | 69 | 4 | this_week | low | scheduled |
| **P3** | Marshall Faulk Parkinson's diagnosis | 61 | 61 | 3 | today | medium | short_term |
| **P5** | Wellness influencer misinformation (Guardian) | 39 | — | — | — | low | monitor |

---

## 6. Editorial Briefs

### P1 — Toothpaste Recall
```yaml
topic: "Brush Buddies EVO toothpaste recall (4.3M+ tubes)"
primary_entity: "Brush Buddies EVO"
signal_type: recall
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 79
opportunity_score: 72
discover_score: 4
urgency: today
confidence: medium
content_status: new
source_count: 7
recommended_angle: "Full affected-product list + parent-focused guidance — what to do if you have one"
why_now: "FDA recall of 4.3M+ tubes breaking across 7+ outlets Oct 21–23, includes children's toothpaste"
primary_headline: "FDA Recalls Over 4 Million Tubes of Toothpaste: Full List of Affected Products and What Parents Should Know"
next_steps: "Confirm direct FDA.gov recall notice URL; compile lot numbers before publishing"
notes: "⚠️ Integrity note: verify FDA.gov notice directly; defect/contamination reason not fully specified in secondary sources"
sources: ["USA Today", "Prevention", "Health.com", "KCRA", "kare11", "News12"]
```

### P1 — GLP-1 Injection Recall
```yaml
topic: "GLP-1 (tirzepatide) injection recall — sterility concerns"
primary_entity: "GLP-1 / tirzepatide injections"
signal_type: recall
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 69
opportunity_score: 80
discover_score: 4
urgency: now
confidence: medium
content_status: new
source_count: 3
recommended_angle: "What GLP-1 users need to know about the recall — sterility concerns explained plainly"
why_now: "Recall breaking Oct 20–21 amid GLP-1 being one of the highest-interest drug categories in search"
primary_headline: "GLP-1 Injections Recalled Nationwide Over Sterility Concerns: What Patients Should Know"
next_steps: "Retrieve FDA.gov notice directly; confirm manufacturer/lot scope before publishing"
notes: "⚠️ Integrity note: confidence capped at Medium via breaking-recall exception — verify before publishing. Confirm if recall is manufacturer-specific vs. class-wide."
sources: ["Good Housekeeping", "Fox Business", "FOX 5 New York"]
```

### P2 — AI Diagnostic Accuracy
```yaml
topic: "AI outperforms physicians on diagnostic accuracy (Microsoft study)"
primary_entity: "Microsoft AI diagnostic study"
signal_type: study_or_research
allowed_category: "medical research and clinical trials"
trend_strength_score: 63
opportunity_score: 67
discover_score: 3
urgency: this_week
confidence: medium
content_status: new
source_count: 3
recommended_angle: "AI beat doctors on a narrow benchmark — pair with Stanford HAI's measurement critique for balanced framing"
why_now: "Converging Medical Economics / Stanford HAI / Nature coverage on AI diagnostic capability and its limits"
primary_headline: "AI Beat Doctors on Diagnosis in a New Study — Here's What That Actually Means for Patients"
next_steps: "Trace claim to original Microsoft paper/preprint; source an AI-in-medicine researcher for context"
notes: "⚠️ Integrity note: distinguish narrow benchmark accuracy from real-world clinical performance; avoid implying AI replaces physicians"
sources: ["Medical Economics", "Stanford HAI", "Nature"]
```

### P3 — Pertussis Global Burden Study
```yaml
topic: "Global Burden of Disease: pertussis resurgence 1990–2023"
primary_entity: "Pertussis (whooping cough)"
signal_type: study_or_research
allowed_category: "infectious disease"
trend_strength_score: 50
opportunity_score: 69
discover_score: 4
urgency: this_week
confidence: low
content_status: new
source_count: 1
recommended_angle: "Translate GBD data into a US-parent-facing explainer on resurging whooping cough and vaccination rates"
why_now: "New Nature-published GBD study quantifies global pertussis resurgence amid falling childhood vaccination"
primary_headline: "Whooping Cough Is Resurging Worldwide, New Global Burden of Disease Study Finds"
next_steps: "Pull full GBD dataset; add CDC US-specific context; source an epidemiologist"
notes: "Confidence low — single-source coverage despite tier-1 credibility; corroborate with CDC data before publishing"
sources: ["Nature"]
```

### P3 — Marshall Faulk Parkinson's Diagnosis
```yaml
topic: "Marshall Faulk reveals Parkinson's diagnosis"
primary_entity: "Marshall Faulk"
signal_type: cultural_moment
allowed_category: "chronic disease management"
trend_strength_score: 61
opportunity_score: 61
discover_score: 3
urgency: today
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Use the disclosure as a hook for an evidence-based explainer on early-onset Parkinson's symptoms/risk factors"
why_now: "Confirmed Google Trends real-time breakout term tied to ESPN disclosure story"
primary_headline: "Marshall Faulk's Parkinson's Diagnosis: What to Know About Early-Onset Parkinson's Disease"
next_steps: "Source a movement-disorder neurologist; cite NIH/Michael J. Fox Foundation prevalence data"
notes: "Keep focus on general disease education, not speculation about personal prognosis"
sources: ["ESPN"]
```

---

## 7. Rejected Topics Log

| Topic | Reason |
|---|---|
| Health insurance costs / employer benefits survey | off_category — healthcare economics/policy |
| Trump/Melania women's health executive order | brand_safety — political framing |
| WHO physician workforce gap | weak_signal — low US audience relevance |
| Hospital mergers (Hackensack/Hunterdon, CentraCare/Stellis) | off_category — local/business news |
| "Wellness darties," supplement strips, local wellness fairs, Therme DC | off_category / low audience scope |
| Oracle-AstraZeneca AI clinical trial partnership | off_category — pure pharma business |
| Rural clinical trial access policy (Congress) | off_category — political/policy |
| PTSD "68% remission" trial | unverifiable_claim — single aggregator, no primary source |
| Cheese recall (E. coli, 13 states) | unverifiable_claim — only 1 source, breaking-recall exception not met |
| "Tea & heart health" rising search | unverifiable_claim — no primary source located; recommend deferred recheck |
| Mental healthcare access study (NJ) | weak_signal — single-state scope |
| Stanford digital-twin preterm labor study | weak_signal — too early-stage/technical |
| "Average human genome" study | weak_signal — moderate interest, deprioritized |
| Alzheimer's Phase 2 trial start | weak_signal — no results yet |
| NIH Vaccinology Center statement | weak_signal — administrative, low direct relevance |
| CAR-T for stiff person syndrome | weak_signal — niche rare disease |
| Wearable device accuracy in trials | off_category — industry/B2B |
| MedShadow drug mix-up recalls batch | weak_signal — single aggregator, low priority |
| Wellness influencer misinformation (Guardian) | **Monitor (P5)** — trend_strength 39 < 50 threshold; single source |

---

## 8. Integrity Flags (Consolidated)

- ⚠️ Toothpaste recall: verify FDA.gov notice directly before publishing.
- ⚠️ GLP-1 recall: confidence capped Medium (breaking-recall exception); verify FDA.gov notice; confirm manufacturer/lot scope.
- ⚠️ AI diagnostic study: avoid conflating narrow benchmark accuracy with real-world clinical performance; do not imply AI replacement of physicians.
- Pertussis study: single-source confidence — corroborate with CDC before publishing.

---

## 9. Run Notes

- No deferred topics past recheck date; no 3+ consecutive-run recurring themes flagged.
- `site_url` not configured — all duplicate/SERP-gap checks used competitor-list fallback per `configs/competitor_list.yaml`.
- Recommend adding "tea & heart health study" to `data/deferred_topics.yaml` with a 3-day recheck given its unusually strong rising-search signal despite no located primary source.
- Women's-health executive order cluster has legitimate health-research substance (new NIH division) — worth revisiting with a depoliticized, policy-neutral angle if coverage persists past the political news cycle.
- Guardian wellness-misinformation piece is a good differentiation angle (skepticism-driven) but didn't clear trend_strength threshold on signal strength alone — hold in Monitor, re-score if additional outlets pick up the story.
- Dashboard and run-history archival steps assumed per standard workflow; not independently executable in this session.